1. Home
  2. TPST vs BODI Comparison

TPST vs BODI Comparison

Compare TPST & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • BODI
  • Stock Information
  • Founded
  • TPST 2011
  • BODI 1998
  • Country
  • TPST United States
  • BODI United States
  • Employees
  • TPST N/A
  • BODI N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • BODI Industrial Machinery/Components
  • Sector
  • TPST Health Care
  • BODI Industrials
  • Exchange
  • TPST Nasdaq
  • BODI Nasdaq
  • Market Cap
  • TPST 45.5M
  • BODI 40.1M
  • IPO Year
  • TPST N/A
  • BODI N/A
  • Fundamental
  • Price
  • TPST $9.58
  • BODI $6.90
  • Analyst Decision
  • TPST Hold
  • BODI Buy
  • Analyst Count
  • TPST 3
  • BODI 2
  • Target Price
  • TPST $30.00
  • BODI $10.00
  • AVG Volume (30 Days)
  • TPST 54.6K
  • BODI 14.7K
  • Earning Date
  • TPST 11-11-2025
  • BODI 11-11-2025
  • Dividend Yield
  • TPST N/A
  • BODI N/A
  • EPS Growth
  • TPST N/A
  • BODI N/A
  • EPS
  • TPST N/A
  • BODI N/A
  • Revenue
  • TPST N/A
  • BODI $324,871,000.00
  • Revenue This Year
  • TPST N/A
  • BODI N/A
  • Revenue Next Year
  • TPST N/A
  • BODI N/A
  • P/E Ratio
  • TPST N/A
  • BODI N/A
  • Revenue Growth
  • TPST N/A
  • BODI N/A
  • 52 Week Low
  • TPST $5.35
  • BODI $3.38
  • 52 Week High
  • TPST $20.67
  • BODI $8.71
  • Technical
  • Relative Strength Index (RSI)
  • TPST 47.99
  • BODI 70.15
  • Support Level
  • TPST $9.90
  • BODI $5.30
  • Resistance Level
  • TPST $11.02
  • BODI $7.29
  • Average True Range (ATR)
  • TPST 0.62
  • BODI 0.47
  • MACD
  • TPST -0.20
  • BODI 0.11
  • Stochastic Oscillator
  • TPST 4.78
  • BODI 82.03

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About BODI The Beachbody Company Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.

Share on Social Networks: